(1-Methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)boronic acid, 95.0%, 250mg

Zinc granules, min. 99.99% pa, particle size 0.3-1.5 mm, 100 g, plastic packaging.

(S)-1-(5-Bromo-pyridin-2-yl)-ethylaminehydrochloride, 95.0%, 1g

5-(1-Benzofuran-2-yl)isoxazole-3-carboxylic acid, 95.0%, 250mg

1,2,4,5-Tetra(1H-imidazol-1-yl)benzene, 98%, 5g

(S)-Benzyl 3-methylpiperazine-1-carboxylate, 95.0%, 1g

1-(3,5-Di-tert-butyl-4-hydroxyphenyl)ethan-1-one, 95+%, 1g

6-Amino-1-methyl-1,3-dihydro-2H-benzo[d]imidazol-2-one hydrochloride, 97%, 100mg

(1R,3S)-3-(1,3-DIOXOISOINDOLIN-2-YL)CYCLOHEXYL ACETATE, 95.0%, 2g

(2-Chloropyridin-4-yl)(3,4-dimethylphenyl)methanone, 95%, 250mg

Ethylene Glycol Dimethacrylate (stabilized with HQ)>97.0%(GC)500mL

Methyl 4-(benzyloxy)-1H-indole-6-carboxylate, 97%, 5g

Single-channel microliter pipette Pipetman® G, 100 to 1000 µl, P1000G, 1 piece